questionsmedicales.fr
Maladies du système nerveux
Tumeurs du système nerveux
Tumeurs du système nerveux central
Tumeurs du système nerveux central : Questions médicales fréquentes
Termes MeSH sélectionnés :
Systematic Reviews as Topic
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du système nerveux central : Questions médicales les plus fréquentes",
"headline": "Tumeurs du système nerveux central : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs du système nerveux central : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-08",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs du système nerveux central"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs du système nerveux",
"url": "https://questionsmedicales.fr/mesh/D009423",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du système nerveux",
"code": {
"@type": "MedicalCode",
"code": "D009423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du cerveau",
"alternateName": "Brain Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D001932",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du cerveau",
"code": {
"@type": "MedicalCode",
"code": "D001932",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs des ventricules cérébraux",
"alternateName": "Cerebral Ventricle Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D002551",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs des ventricules cérébraux",
"code": {
"@type": "MedicalCode",
"code": "D002551",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du plexus choroïde",
"alternateName": "Choroid Plexus Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D016545",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D016545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Papillome du plexus choroïde",
"alternateName": "Papilloma, Choroid Plexus",
"url": "https://questionsmedicales.fr/mesh/D020288",
"about": {
"@type": "MedicalCondition",
"name": "Papillome du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D020288",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Papillome du plexus choroïde",
"alternateName": "Papilloma, Choroid Plexus",
"url": "https://questionsmedicales.fr/mesh/D020288",
"about": {
"@type": "MedicalCondition",
"name": "Papillome du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D020288",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs du plexus choroïde",
"alternateName": "Choroid Plexus Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D016545",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D016545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Papillome du plexus choroïde",
"alternateName": "Papilloma, Choroid Plexus",
"url": "https://questionsmedicales.fr/mesh/D020288",
"about": {
"@type": "MedicalCondition",
"name": "Papillome du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D020288",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Papillome du plexus choroïde",
"alternateName": "Papilloma, Choroid Plexus",
"url": "https://questionsmedicales.fr/mesh/D020288",
"about": {
"@type": "MedicalCondition",
"name": "Papillome du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D020288",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs sous-tentorielles",
"alternateName": "Infratentorial Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D015192",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs sous-tentorielles",
"code": {
"@type": "MedicalCode",
"code": "D015192",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du tronc cérébral",
"alternateName": "Brain Stem Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D020295",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D020295",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gliome infiltrant du tronc cérébral",
"alternateName": "Diffuse Intrinsic Pontine Glioma",
"url": "https://questionsmedicales.fr/mesh/D000080443",
"about": {
"@type": "MedicalCondition",
"name": "Gliome infiltrant du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D000080443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gliome infiltrant du tronc cérébral",
"alternateName": "Diffuse Intrinsic Pontine Glioma",
"url": "https://questionsmedicales.fr/mesh/D000080443",
"about": {
"@type": "MedicalCondition",
"name": "Gliome infiltrant du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D000080443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs du cervelet",
"alternateName": "Cerebellar Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D002528",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du cervelet",
"code": {
"@type": "MedicalCode",
"code": "D002528",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.300"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs du tronc cérébral",
"alternateName": "Brain Stem Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D020295",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D020295",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gliome infiltrant du tronc cérébral",
"alternateName": "Diffuse Intrinsic Pontine Glioma",
"url": "https://questionsmedicales.fr/mesh/D000080443",
"about": {
"@type": "MedicalCondition",
"name": "Gliome infiltrant du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D000080443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gliome infiltrant du tronc cérébral",
"alternateName": "Diffuse Intrinsic Pontine Glioma",
"url": "https://questionsmedicales.fr/mesh/D000080443",
"about": {
"@type": "MedicalCondition",
"name": "Gliome infiltrant du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D000080443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs du cervelet",
"alternateName": "Cerebellar Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D002528",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du cervelet",
"code": {
"@type": "MedicalCode",
"code": "D002528",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neurocytome",
"alternateName": "Neurocytoma",
"url": "https://questionsmedicales.fr/mesh/D018306",
"about": {
"@type": "MedicalCondition",
"name": "Neurocytome",
"code": {
"@type": "MedicalCode",
"code": "D018306",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pinéalome",
"alternateName": "Pinealoma",
"url": "https://questionsmedicales.fr/mesh/D010871",
"about": {
"@type": "MedicalCondition",
"name": "Pinéalome",
"code": {
"@type": "MedicalCode",
"code": "D010871",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs sus-tentorielles",
"alternateName": "Supratentorial Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D015173",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs sus-tentorielles",
"code": {
"@type": "MedicalCode",
"code": "D015173",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.700"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs de l'hypothalamus",
"alternateName": "Hypothalamic Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D007029",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de l'hypothalamus",
"code": {
"@type": "MedicalCode",
"code": "D007029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.700.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs de l'hypothalamus",
"alternateName": "Hypothalamic Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D007029",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de l'hypothalamus",
"code": {
"@type": "MedicalCode",
"code": "D007029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.700.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs des méninges",
"alternateName": "Meningeal Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D008577",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs des méninges",
"code": {
"@type": "MedicalCode",
"code": "D008577",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méningite carcinomateuse",
"alternateName": "Meningeal Carcinomatosis",
"url": "https://questionsmedicales.fr/mesh/D055756",
"about": {
"@type": "MedicalCondition",
"name": "Méningite carcinomateuse",
"code": {
"@type": "MedicalCode",
"code": "D055756",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.500.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Méningiome",
"alternateName": "Meningioma",
"url": "https://questionsmedicales.fr/mesh/D008579",
"about": {
"@type": "MedicalCondition",
"name": "Méningiome",
"code": {
"@type": "MedicalCode",
"code": "D008579",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs de la moelle épinière",
"alternateName": "Spinal Cord Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D013120",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de la moelle épinière",
"code": {
"@type": "MedicalCode",
"code": "D013120",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs épidurales",
"alternateName": "Epidural Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D015174",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs épidurales",
"code": {
"@type": "MedicalCode",
"code": "D015174",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.750.200"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du système nerveux central",
"alternateName": "Central Nervous System Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D016543",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christian Grommes",
"url": "https://questionsmedicales.fr/author/Christian%20Grommes",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Daniel R Rissi",
"url": "https://questionsmedicales.fr/author/Daniel%20R%20Rissi",
"affiliation": {
"@type": "Organization",
"name": "University of Georgia, Athens, GA."
}
},
{
"@type": "Person",
"name": "Lakshmi Nayak",
"url": "https://questionsmedicales.fr/author/Lakshmi%20Nayak",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: Lakshmi_Nayak@dfci.harvard.edu."
}
},
{
"@type": "Person",
"name": "Ammar A Chaudhry",
"url": "https://questionsmedicales.fr/author/Ammar%20A%20Chaudhry",
"affiliation": {
"@type": "Organization",
"name": "Precision Imaging Lab, Department of Diagnostic Radiology, City of Hope National Cancer Center, 1500 East Duarte Road, Los Angeles, CA 91010, USA. Electronic address: achaudhry@coh.org."
}
},
{
"@type": "Person",
"name": "Sohaib Naim",
"url": "https://questionsmedicales.fr/author/Sohaib%20Naim",
"affiliation": {
"@type": "Organization",
"name": "Department of Diagnostic Radiology, City of Hope National Cancer Center, 1500 East Duarte Road, Los Angeles, CA 91010, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A systematic meta-review of systematic reviews on attention deficit hyperactivity disorder.",
"datePublished": "2023-11-17",
"url": "https://questionsmedicales.fr/article/37974470",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1192/j.eurpsy.2023.2451"
}
},
{
"@type": "ScholarlyArticle",
"name": "Is the quality of systematic reviews influenced by prospective registration: a methods review of systematic musculoskeletal physical therapy reviews.",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35942578",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/10669817.2022.2110419"
}
},
{
"@type": "ScholarlyArticle",
"name": "Disinvestment in healthcare: a scoping review of systematic reviews.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35853843",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/S0266462322000514"
}
},
{
"@type": "ScholarlyArticle",
"name": "Critical Appraisal of a Systematic Review: A Concise Review.",
"datePublished": "2022-07-18",
"url": "https://questionsmedicales.fr/article/35853198",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/CCM.0000000000005602"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effectiveness of exercise interventions in the management of cancer-related fatigue: a systematic review of systematic reviews.",
"datePublished": "2023-02-07",
"url": "https://questionsmedicales.fr/article/36746815",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00520-023-07619-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009423"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D016543"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs du système nerveux central - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs du système nerveux central",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs du système nerveux central",
"description": "Comment diagnostique-t-on une tumeur du SNC ?\nQuels tests sont utilisés pour évaluer une tumeur cérébrale ?\nQuels marqueurs tumoraux sont associés aux tumeurs du SNC ?\nQuelle est l'importance de l'imagerie dans le diagnostic ?\nPeut-on diagnostiquer une tumeur du SNC par échographie ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Systematic+Reviews+as+Topic&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs du système nerveux central",
"description": "Quels sont les symptômes courants des tumeurs du SNC ?\nComment les tumeurs affectent-elles la fonction cognitive ?\nLes tumeurs du SNC causent-elles des convulsions ?\nQuels signes neurologiques peuvent indiquer une tumeur ?\nLes tumeurs du SNC provoquent-elles des changements d'humeur ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Systematic+Reviews+as+Topic&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs du système nerveux central",
"description": "Peut-on prévenir les tumeurs du SNC ?\nLes radiations augmentent-elles le risque de tumeurs du SNC ?\nLes infections virales peuvent-elles causer des tumeurs du SNC ?\nLe mode de vie influence-t-il le risque de tumeurs du SNC ?\nLes antécédents familiaux augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Systematic+Reviews+as+Topic&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs du système nerveux central",
"description": "Quels sont les traitements possibles pour les tumeurs du SNC ?\nQuand la chirurgie est-elle recommandée pour une tumeur du SNC ?\nQuel rôle joue la radiothérapie dans le traitement ?\nLa chimiothérapie est-elle efficace contre toutes les tumeurs du SNC ?\nQuels sont les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Systematic+Reviews+as+Topic&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs du système nerveux central",
"description": "Quelles complications peuvent survenir après un traitement ?\nLes tumeurs du SNC peuvent-elles causer des problèmes de mobilité ?\nComment les tumeurs affectent-elles la qualité de vie ?\nLes tumeurs du SNC peuvent-elles entraîner des crises d'épilepsie ?\nQuelles sont les conséquences psychologiques des tumeurs du SNC ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Systematic+Reviews+as+Topic&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs du système nerveux central",
"description": "Quels sont les principaux facteurs de risque des tumeurs du SNC ?\nL'âge influence-t-il le risque de tumeurs du SNC ?\nLes troubles immunitaires augmentent-ils le risque ?\nLes produits chimiques peuvent-ils être un facteur de risque ?\nLes infections antérieures influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Systematic+Reviews+as+Topic&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une tumeur du SNC ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par IRM, scanner et biopsie pour analyser les cellules."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer une tumeur cérébrale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'IRM, le scanner et des tests neurologiques pour évaluer la fonction."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés aux tumeurs du SNC ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme le GFAP et l'IDH peuvent être utilisés pour certaines tumeurs."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'imagerie dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie permet de localiser la tumeur, d'évaluer sa taille et son impact sur le SNC."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer une tumeur du SNC par échographie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie est rarement utilisée pour le SNC, l'IRM et le scanner sont préférés."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des tumeurs du SNC ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées, des troubles de la vision et des convulsions."
}
},
{
"@type": "Question",
"name": "Comment les tumeurs affectent-elles la fonction cognitive ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des troubles de la mémoire, de la concentration et des changements de personnalité."
}
},
{
"@type": "Question",
"name": "Les tumeurs du SNC causent-elles des convulsions ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les convulsions sont fréquentes et peuvent être un signe d'une tumeur cérébrale."
}
},
{
"@type": "Question",
"name": "Quels signes neurologiques peuvent indiquer une tumeur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la faiblesse musculaire, des engourdissements ou des troubles de l'équilibre peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les tumeurs du SNC provoquent-elles des changements d'humeur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements d'humeur et des comportements peuvent survenir en raison de la pression sur le cerveau."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les tumeurs du SNC ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention garantie, mais éviter les expositions nocives peut aider."
}
},
{
"@type": "Question",
"name": "Les radiations augmentent-elles le risque de tumeurs du SNC ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux radiations ionisantes est un facteur de risque connu pour ces tumeurs."
}
},
{
"@type": "Question",
"name": "Les infections virales peuvent-elles causer des tumeurs du SNC ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le virus Epstein-Barr, sont associées à un risque accru."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque de tumeurs du SNC ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire certains risques, mais les causes exactes restent souvent inconnues."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de tumeurs cérébrales peuvent augmenter le risque individuel."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements possibles pour les tumeurs du SNC ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et la chimiothérapie selon le type de tumeur."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle recommandée pour une tumeur du SNC ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est souvent recommandée si la tumeur est accessible et peut être retirée sans risque majeur."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la radiothérapie dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie est utilisée pour détruire les cellules tumorales, souvent après la chirurgie."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace contre toutes les tumeurs du SNC ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, son efficacité varie selon le type de tumeur; certaines sont plus sensibles que d'autres."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure fatigue, nausées, troubles neurologiques et perte de cheveux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après un traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des déficits neurologiques, des infections et des récidives tumorales."
}
},
{
"@type": "Question",
"name": "Les tumeurs du SNC peuvent-elles causer des problèmes de mobilité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent affecter la coordination et la force, entraînant des problèmes de mobilité."
}
},
{
"@type": "Question",
"name": "Comment les tumeurs affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des douleurs, des troubles cognitifs et des impacts émotionnels significatifs."
}
},
{
"@type": "Question",
"name": "Les tumeurs du SNC peuvent-elles entraîner des crises d'épilepsie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des crises d'épilepsie, nécessitant un traitement antiepileptique."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences psychologiques des tumeurs du SNC ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent éprouver anxiété, dépression et stress en raison de leur condition."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque des tumeurs du SNC ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition aux radiations, les antécédents familiaux et certaines maladies génétiques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de tumeurs du SNC ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, bien que certaines tumeurs puissent survenir chez les jeunes."
}
},
{
"@type": "Question",
"name": "Les troubles immunitaires augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des troubles immunitaires ont un risque accru de développer des tumeurs."
}
},
{
"@type": "Question",
"name": "Les produits chimiques peuvent-ils être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines expositions professionnelles à des produits chimiques sont suspectées d'augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les infections antérieures influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections, comme le VIH, peuvent augmenter le risque de tumeurs du SNC."
}
}
]
}
]
}
There are now hundreds of systematic reviews on attention deficit hyperactivity disorder (ADHD) of variable quality. To help navigate this literature, we have reviewed systematic reviews on any topic ...
We searched MEDLINE, PubMed, PsycINFO, Cochrane Library, and Web of Science and performed quality assessment according to the Joanna Briggs Institute Manual for Evidence Synthesis. A total of 231 syst...
The prevalence of ADHD was 7.2% for children and adolescents and 2.5% for adults, though with major uncertainty due to methodological variation in the existing literature. There is evidence for both b...
Despite hundreds of systematic reviews on ADHD, key questions are still unanswered. Evidence gaps remain as to a more accurate prevalence of ADHD, whether documented risk factors are causal, the effic...
It is unknown if verified prospective registration of systematic reviews (SRs) and the randomized clinical trials (RCTs) that they use affect an SR's methodological quality on A MeaSurement Tool to As...
Data originated from interventional SRs published in International Society of Physiotherapy Journals Editors (ISPJE) member journals, indexed in MEDLINE, between 1 January 2018 and 18 August 2021. Bli...
Two of 14 ISPJE member journals required prospective SR registration. Twenty SRs were identified, and 169 unique, retrievable RCTs were included within those SRs. One (5.0%) of the 20 SRs and 15 of th...
SRs and the RCTs identified within them were infrequently prospectively registered, prospectively verifiable, or prospectively verified based on the established research record....
Ensuring that SRs and RCTs have fidelity with the research record from conception to publication may help rule out low-value interventions, decrease variability in physical therapy practice, and solid...
Disinvestment from low value health technologies is growing globally. Diverse evidence gathering and assessment methods were used to implement disinvestment initiatives, however, less than half of the...
This scoping review was guided by the Joanna Briggs Institute Manual for Evidence Synthesis and PRISMA statement for scoping review. Published reviews on disinvestment were identified from scientific ...
Seventeen reviews were included with thirty-four initiatives identified across sixteen countries at various levels of implementation and responsible agencies for the activities. Two most used methods ...
Disinvestment programs have been implemented at multilevel, involving multistakeholders and using multiple methods such as PBMA and HTA. However, there is a lack of clarity on the additional dimension...
Concise definitive review of how to read and critically appraise a systematic review....
None....
Current literature describing the conduct, reporting, and appraisal of systematic reviews and meta-analyses....
Best practices for conducting, reporting, and appraising systematic review were summarized....
A systematic review is a review of a clearly formulated question that uses systematic and explicit methods to identify, select, and critically appraise relevant original research, and to collect and a...
Systematic reviews are transparent and reproducible summaries of research and conclusions drawn from them are only as credible and reliable as their development process and the studies which form the ...
Cancer-related fatigue is a widely prevalent global public health concern with serious consequences. Increasing evidence suggests the effectiveness of exercise intervention in treating cancer-related ...
To summarize evidence regarding the efficacy of exercise interventions to reduce cancer fatigue, as determined in systematic reviews (SRs) and/or meta-analyses (MAs)....
From inception to September 2022, PubMed (1948-2022), Embase (1974-2022), Cochrane Library (1993-2022), CINAHL (1937-2022), Web of Science (1997-2022), China Knowledge Resource Integrated Database (19...
A total of 46 systematic reviews were assessed for data on exercise intervention in reducing cancer-related fatigue among cancer patients. In addition, some studies have reported adverse events during...
The present systematic review of systematic reviews supports exercise intervention for reducing cancer-related fatigue. Further higher-quality studies are warranted to improve the level of evidence fo...
Endometriosis is a chronic gynecologic condition that affects around 6-10% of reproductive age women. This clinical entity is characterized with pelvic pain, dysmenorrhea, dyspareunia, and infertility...
To compare and summarize the literature regarding infodemics and health misinformation, and to identify challenges and opportunities for addressing the issues of infodemics....
We searched MEDLINE®, Embase®, Cochrane Library of Systematic Reviews, Scopus and Epistemonikos on 6 May 2022 for systematic reviews analysing infodemics, misinformation, disinformation and fake news ...
Our search identified 31 systematic reviews, of which 17 were published. The proportion of health-related misinformation on social media ranged from 0.2% to 28.8%. Twitter, Facebook, YouTube and Insta...
Available evidence suggests that infodemics during health emergencies have an adverse effect on society. Multisectoral actions to counteract infodemics and health misinformation are needed, including ...
Arthroscopic partial meniscectomy (APM) is widely applied for the treatment of degenerative meniscal lesions in middle-aged patients; however, such injury is often associated with mild or moderate ost...
Two authors independently searched PubMed and Google Scholar for SRs comparing the outcome (in knee pain and functionality) of arthroscopic treatment and exercise therapy or placebo for degenerative m...
A total of 13 SRs were selected. Two reviewers independently assessed the methodological quality of each paper using the AMSTAR 2 tool: seven scored as "moderate," four obtained a "low" grade while th...
Conservative treatment based on physical therapy should be the first-line management. However, most SRs revealed subgroups of patients that fail to improve after conservative treatment and find relief...
Medication reviews aim to support patients who take medicines, and they are often led by pharmacists. There are different types of medication reviews undertaken in various settings. Previous research ...
This scoping review aims to explore the extent and range of systematic reviews of medication reviews conducted by pharmacists, the nature of the intervention, the evidence for effectiveness, and repor...
Systematic reviews were included irrespective of participants, settings or outcomes and were excluded if pharmacists did not lead the delivery of the included interventions. Data extracted included th...
We identified twenty-four systematic reviews that reported that medication review interventions were diverse, and their nature was often poorly described. Two high-quality reviews reported that there ...
There is mixed evidence of effectiveness for medication reviews across settings and patient populations. There is limited data about the implementation of medication reviews, therefore is difficult to...
A systematic review (SR) helps us make sense of a body of research while minimizing bias and is routinely conducted to evaluate intervention effects in a health technology assessment (HTA). In additio...
We identified key factors and considerations that can inform the process of deciding to conduct one review type over the others to answer a research question and organized them into guidance comprisin...
Nine key factors and six considerations were identified to help reviewers select the most appropriate review type to conduct. These fell into one of two categories: the evidentiary needs of the planne...
Selecting the most appropriate review type to conduct when evaluating intervention effects in an HTA requires a myriad of factors to be considered. We hope this guidance adds clarity to the many compe...